Biomedical Industry Policies and Resources
•The Future Blueprint of Taiwan’s Biomedical Industry
•Description: This session will feature high-level representatives from the Small and Medium Enterprise Administration (SMEA), Taiwan Food and Drug Administration (TFDA), Science Parks, and Biomedical Technology and Device Research Laboratories of ITRI, who will engage in a deep dive into the future development roadmap and policy support for Taiwan’s biomedical industry.
Discussions will focus on how global trends are shaping Taiwan’s biomedical ecosystem and strengthening its global competitiveness.
Attendees will gain valuable first-hand insights into government policies and resources, empowering enterprises to align with national strategies and expand into global markets.
Discussions will focus on how global trends are shaping Taiwan’s biomedical ecosystem and strengthening its global competitiveness.
Attendees will gain valuable first-hand insights into government policies and resources, empowering enterprises to align with national strategies and expand into global markets.
•Government Resources for the Biotech Industry
•Description: This session will be led by experts from public research institutions, highlighting how biotech companies can leverage government resources and support programs for growth. Key topics include:Government initiatives supporting scientific R&D and startup incubation, Industrial upgrading and transformation, Quality improvement in cell therapy, Medical device development and regulatory pathways. This session is designed to help SMEs strengthen their technological capabilities, accelerate commercialization, and strategically access critical government support.